期刊文献+

锌指蛋白A20在炎症性肠病患儿肠黏膜中的表达及意义 被引量:9

Expression of zinc finger protein A20 in pediatric infiammatory bowel disease
原文传递
导出
摘要 【摘要】目的探讨炎症性肠病(IBD)患儿肠道炎症反应与锌指蛋白A20(A20)表达水平之间的关系。方法收集2008至2010年就诊于我院并行肠镜检查的患儿肠道黏膜标本共57份。将标本分为正常对照组(It=16)、IBD缓解期组(It=12)、IBD活动期组(n=13)和非IBD肠炎组(n=16)。内镜下取各组患儿末端回肠黏膜标本,采用荧光定量PCR和免疫组化法检测A20、NF—KB、IL-6、IL-8的表达水平。结果(1)NF—KB、A20在正常对照组肠黏膜中仅微量表达,IBD活动期组和非IBD肠炎组NF—KB、A20表达水平明显高于正常对照组(P均〈0.01);(2)IBD缓解期组较正常对照组NF—KB[(9.35±4.84)%vs(0.57±0.44)%,P〈0.011、IL_6(t'=1.34,P〉0.05)、IL-8(t=1.38,P〉0.05)表达水平高,而A20在mRNA水平(t=1.03,P〉0.05)和蛋白水平[(0.36±0.18)%vs(0.87±0.29)%,P〈0.01]上表达均偏低;(3)与非IBD肠炎组相比,IBD活动期组NF—KB[(24.17±11.27)%vs(55.29±21.84)%,P〈0.01]、IL-6(t=2.22,P〈0.05)、IL-8(t=2.97,P〈0.01)表达水平明显升高,而A20在mRNA(t=2.26,P〈0.05)和蛋白水平[(29.23±11.70)%VS(16.814-5.90)%,P〈0.01]上表达均较低;(4)IBD缓解期组与非IBD肠炎组相比,IL-6、IL-8表达水平差异无统计学意义(t'值和t值分别为0.03和0.28,P均〉0.05),而A20在mRNA水平(t=4.42,P〈0.01)和蛋白水平[(29.23±11.70)%vs(0.47±0.25)%,P〈0.01]上表达均较低。结论IBD患儿存在肠道炎症反应过度而A20表达水平上调不足的现象;A20表达水平的异常可能参与了IBD的发生和发展。 Objective It is demonstrated that excessive activation of NF-KB is central to the pathogenesis of inflammatory bowel disease (IBD). Zinc finger protein A20 (A20) is a key player in the negative feedback regulation of NF-KB signaling in response to multiple stimuli and has been described as central gatekeeper in inflammation and immunity. Mice genetically deficient in A20 develop severe intestinal inflammation and have increased susceptibility to dextran sodium sulfate(DSS)-induced colitis. Few studies have been done to explore the role of A20 in the pathogenesis of IBD. To clarify the relationship between intestinal inflammation and the expression level of A20 in IBD patients, the expression level of A20 and a series of inflammatory cytokines, such as NF-KB, IL-6, and IL-8, in children with IBD and controls were examined. Method Terminal ileal mucosal samples were obtained via endoscopy. Fifty-seven mueosal samples were divided into 4 groups: normal control group (n = 16 ), IBD remission group (n -- 12 ) , IBD active group (n = 13) and non-IBD enteritis group (n = 16). According to disease activity index scores, the IBD patients were divided into IBD remission group and IBD active group. Normal control group was consisted of patients with functional bowel disorders or intestinal polyps. Non-IBD enteritis was defined as changes in which endoscopy and histological examination showed inflammatory changes but could not be diagnosed as IBD. Real-time PCR was adopted for detecting the mRNA levels of A20, IL-6 and IL-8. Meanwhile immunohistoehemistry was performed to measure the expression of A20 and NF-KB. Result ( 1 ) The expression of A20 and NF-KB were very low in normal control group, but significantly up-regulated in IBD active group and non-IBD enteritis group ( P 〈 0. 01 for both) ; (2) Compared with normal control group, expression of NF-KB [(9.35±4. 84)% vs. (0.57±0.44)%, P〈0.01], IL-6 (t'=1.34, P〉0. 05 ), IL-8 (t = 1.38, P 〉 0. 05 ) increased in IBD remission group, while the expression of A20 in both mRNA (t=1.03, P〉0.05) and protein levels [(0.36±0.18)% vs. (0.87±0.29)%, P〈0.01] decreased; (3) Compared with non-IBD enteritis group, although the expression of NF-KB [ (24. 17±11.27)% vs. (55.29±21.84)%, P〈0.01], IL-6 (t=2.22, P〈0.05), IL-8 (t =2.97, P〈0.01) were highly increased in IBD active group, the expression of A20 in both mRNA( t = 2. 26, P 〈 0. 05 ) and protein levels [ (29.23 _+ 11.70) % vs. ( 16.81 + 5.90 ) % , P 〈 0. 01 ] significantly decreased ; (4) The expression of IL-6, IL-8 were similar in IBD remission group and non-IBD enteritis group ( both P 〉 0. 05 ), but the expression of A20 was much lower in both mRNA (t = 4.42, P 〈 0. 01 ) and protein levels [ (29.23±11.70)% vs. (0.47±0.25)%, P 〈 0.01] in IBD remission group. Conclusion The results demonstrate that there is an excessive inflammatory response but insufficient up-regulation of A20 expression in IBD patients. Low levels expression of A20 may play an important role in the pathogenesis of IBD.
作者 郑翠芳 黄瑛
出处 《中华儿科杂志》 CAS CSCD 北大核心 2011年第4期261-265,共5页 Chinese Journal of Pediatrics
关键词 NF—kappa B 炎性肠疾病 儿童 锌指蛋白A20 NF-KB Inflammatory bowel disease Child Zinc finger protein A20
  • 相关文献

参考文献20

  • 1Neurath MF,Pettersson S,Meyer zum Büschenfelde KH,et al.Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice.Nat Med,1996,2:998-1004.
  • 2Thiele K,Bierhaus A,Autschbach F,et al.Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease.Gut,1999,45:693-704.
  • 3Atreya I,Atreya R,Neurath MF.NF-kappaB in inflammatory bowel disease.J Intern Med,2008,263:591-596.
  • 4Heyninck K,Beyaert R.A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.Trends Biochem Sci,2005,30:1-4.
  • 5Coornaert B,Carpentier I,Beyaert R.A20:central gatekeeper in inflammation and immunity.J Biol Chem,2009,284:8217-8221.
  • 6Hitotsumatsu O,Ahmad RC,Tavares R,et al.The ubiquitinediting enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals.Immunity,2008,28:381-390.
  • 7Lee EG,Boone DL,Chai S,et al.Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.Science,2000,289:2350-2354.
  • 8Boone DL,Turer EE,Lee EG,et al.The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.Nat Immunol,2004,5:1052-1060.
  • 9Turer EE,Tavares RM,Mortier E,et al.Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20.J Exp Med,2008,205:451-464.
  • 10Vereecke L,Sze M,Guire CM,et al.Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.J Exp Med,2010,207:1513-1523.

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413.
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753.
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385.
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643.
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15.
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16.
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献750

同被引文献123

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部